HF
CBAY

HRT Financial’s Cymabay Therapeutics CBAY Stock Holding History

HRT Financial’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-385,676
Closed -$3.36M – 3579
2023
Q1 		$3.36M Buy
385,676
+311,482
+420% +$2.49M 0.04% 387
2022
Q4 		$465K Buy
+74,194
New +$282K 0.01% 1479
2021
Q4 		– Sell
-51,853
Closed -$189K – 4374
2021
Q3 		$189K Buy
+51,853
New +$204K ﹤0.01% 2714
2021
Q1 		– Sell
-104,393
Closed -$599K – 3318
2020
Q4 		$599K Buy
+104,393
New +$790K 0.01% 928
2020
Q3 		– Sell
-13,864
Closed -$48K – 2535
2020
Q2 		$48K Buy
+13,864
New +$40K ﹤0.01% 1318
2019
Q4 		– Sell
-22,633
Closed -$115K – 1791
2019
Q3 		$115K Buy
+22,633
New +$137K 0.01% 1232
2018
Q4 		– Sell
-24,709
Closed -$273K – 784
2018
Q3 		$273K Buy
+24,709
New +$307K 0.05% 267

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return